How does lurbinectedin affect DNA repair?
Lurbinectedin acts primarily by interfering with the transcription machinery in cancer cells. That matters for DNA repair because many DNA repair pathways depend on newly made RNA and ongoing transcriptional programs after DNA damage. By disrupting transcription, lurbinectedin reduces the cell’s ability to coordinate repair of DNA lesions, which can make damage accumulate and push cells toward death rather than recovery.
Which DNA repair steps does lurbinectedin disrupt?
The exact repair steps most affected are tied to the type of DNA damage and which repair pathways a tumor relies on. Broadly, when transcription is impaired, cells struggle to execute damage-response signaling and to produce repair-related factors needed to restore DNA integrity. That creates a functional “repair inhibition” effect even if lurbinectedin does not directly block a single named repair enzyme.
Why does inhibiting DNA repair make lurbinectedin effective in some cancers?
Cancer cells often sit closer to the edge of tolerating genomic stress than normal cells. If lurbinectedin prevents cells from effectively responding to DNA damage, they accumulate lethal genomic damage faster than they can repair it, which can increase tumor cell killing.
How is this different from classic DNA repair inhibitors?
Many well-known “DNA repair inhibitors” target one repair pathway directly (for example, inhibiting a specific enzyme or complex in homologous recombination or base excision repair). Lurbinectedin’s role is better described as indirect via transcriptional disruption: it undermines the cell processes that repair pathways depend on, rather than blocking a single repair target.
What determines whether DNA repair inhibition will work?
Tumors vary in which DNA repair networks they rely on. If a cancer depends heavily on transcription-coupled damage responses, it may be more sensitive when transcription is disrupted. If it can shift to alternative repair routes or has strong baseline repair capacity, the functional impact on repair may be smaller.
Where can I verify the mechanistic details?
For a cross-check of lurbinectedin’s mechanism and development status, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/?s=lurbinectedin
Sources cited
1. https://www.drugpatentwatch.com/?s=lurbinectedin